St Istvan St Laszlo hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02691130
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

inactivated influenza vaccine (1 trial)

multimeric-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2